Komal L. Jhaveri, MD, Assistant Professor, Department of Medicine, NYU Langone Medical Center, discusses the background and results of a study looking at crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC).
Komal L. Jhaveri, MD, Assistant Professor, Department of Medicine, NYU Langone Medical Center, discusses the background and results of a study looking at crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC).
The goal of this analysis was to satisfy an unmet need and understand what molecular pathways are relevant in IBC. The laboratory at the NYU Langone Medical Center has done important work with the PI3K/AKT/mTOR pathway and is aware of its relevancy in many disease types, including breast cancer.
IBCs express a lot of tumor-activated macrophages, Jhaveri says, which leads to the activation of certain signaling molecules, such as cytokines, which leads to the activation of the JAK/STAT signaling pathway.
This research team set out to understand and flesh out what was already known about the PI3K/AKT and JAK/STAT pathways as well as determine what pathways are important and activated in IBC.
The study found that in IBC, Jhaveri says, the PI3K/AKT/mTOR pathway was activated. Additionally, of the patients with an mTOR pathway activation, a very high proportion also had JAK/STAT pathway activation as well as the IL-6 and CD163 activations.
Batalini Explores Role of UGT1A1 in Patients Treated With Sacituzumab Govitecan for HR+ MBC
April 22nd 2024During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, discussed the TROPiCS-02 trial of sacituzumab govitecan and the impact of the UGT1A1 status on adverse event frequency.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen